Skip to main content

Table 1 Characteristics of the Study Population (flowcytometry) (n = 6)

From: Selective accumulation of langerhans-type dendritic cells in small airways of patients with COPD

subject

1

2

3

4

5

6

gender

M

M

F

M

M

M

Age (years)

60

76

63

67

77

69

Smoking history (packyear)

0

0

40

40

35

50

Current or ex smoker

NA

NA

current

current

ex

ex

FEV1 (%pred)

77.0

111.0

94.0

97.0

74

75.0

FEV 1 (L)

2.4

3.0

1.8

2.9

1.9

1.9

FEV 1 /FVC (%)

70

76

68

68

64

58

LABA (Yes/No)

No

No

No

No

No

No

Inhaled CS (Yes/No)

No

No

No

No

No

No

Systemic CS (Yes/No)

No

No

No

No

No

No

Study group

Never Smoker

Never Smoker

COPD*

COPD*

COPD*

COPD*

% Langerin + cells

2.0

5.4

1.7

1.0

0.9

16.5

% DC-SIGN + cells

2.0

14.1

0.8

0.7

1.0

2.9

% BDCA-1 + cells

4.2

14.2

2.5

2.0

2.5

13.4

% BDCA-3 high + cells

20.0

3.7

6.0

7.9

2.5

4.0

% BDCA-1+ cells on LDC

73.5

88.0

80.8

75.0

64.1

14.2

  1. Data are provided per subject. CS: corticosteroids; FEV1: forced expiratory volume in one second postbronchodilator; FVC: forced vital capacity; LABA : long acting β 2 agonist; M: Male, F: Female; (*): spirometry-based diagnosis of COPD according to GOLD criteria.
  2. Flowcytometric data on single cell suspensions are presented as % of HLA-DR positive cells within the low autofluorescent, CD3 negative, CD19 negative cell population. LDC: langerhans-type dendritic cell